Roivant Sciences Ltd. · NASDAQ:ROIV
Torti Frank reported 7 trades in Roivant Sciences Ltd. shares (Form 4)
Traded Nov 10 to Nov 12, 2026 · Filed Nov 12, 2026
From Nov 10 to Nov 12, 2026, Torti Frank (President and Vant Chair) reported 7 trades in Roivant Sciences Ltd. shares at an average US$41.03 for US$48.3M, leaving 12,306,950 shares. Filed Nov 12, 2026 (Form 4).
- Shares
- 1,176,143 shares
- Price
- US$41.03 average (US$40.36 to US$42.01)
- Value
- US$48.3M
- Holding after
- 12,306,950 shares
- Trading plan
- No
- Role
- President and Vant Chair
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Shares | Other | 173,683 | US$40.43 | 13,322,210 | Direct |
| Nov 10, 2026 | Common Shares | Other | 218,369 | US$41.13 | 13,103,841 | Direct |
| Nov 11, 2026 | Common Shares | Other | 240,755 | US$41.63 | 12,863,086 | Direct |
| Nov 11, 2026 | Common Shares | Other | 151,293 | US$42.01 | 12,711,793 | Direct |
| Nov 12, 2026 | Common Shares | Other | 329,550 | US$40.36 | 12,382,243 | Direct |
| Nov 12, 2026 | Common Shares | Other | 62,493 | US$41.13 | 12,319,750 | Direct |
| Nov 12, 2026 | Common Shares | Shares withheld for tax | 12,800 | US$41.85 | 12,306,950 | Direct |
Source
Download original · View original at SEC
Related
- Roivant Sciences Ltd.
- Torti Frank
- Roivant Sciences Ltd. shareholders
- Form 4 · Torti Frank · Oct 2, 2026
- Form 4 · Torti Frank · Jul 2, 2026
- Form 4 · Torti Frank · Apr 2, 2026
- Form 4 · Gold Daniel Allen · Nov 18, 2026
- Form 4 · QVT Financial LP · Nov 18, 2026
- Form 4 · Manchester Keith S · Nov 18, 2026
- Form 4 · Sukhatme Mayukh · Nov 12, 2026
- Form 4 · Gline Matthew · Nov 12, 2026